Pyridostigmine bromide exposure creates chronic, underlying neuroimmune disruption in the gastrointestinal tract and brain that alters responses to palmitoylethanolamide in a mouse model of Gulf War Illness.

MLA

Hernandez, Siomara, et al. “Pyridostigmine Bromide Exposure Creates Chronic, Underlying Neuroimmune Disruption in the Gastrointestinal Tract and Brain That Alters Responses to Palmitoylethanolamide in a Mouse Model of Gulf War Illness.” Neuropharmacology, vol. 179, Nov. 2020, p. 108264. EBSCOhost, https://doi.org/10.1016/j.neuropharm.2020.108264.

APA

Hernandez, S., Morales-Soto, W., Grubišić, V., Fried, D., & Gulbransen, B. D. (2020). Pyridostigmine bromide exposure creates chronic, underlying neuroimmune disruption in the gastrointestinal tract and brain that alters responses to palmitoylethanolamide in a mouse model of Gulf War Illness. Neuropharmacology, 179, 108264. https://doi.org/10.1016/j.neuropharm.2020.108264

Chicago

Hernandez, Siomara, Wilmarie Morales-Soto, Vladimir Grubišić, David Fried, and Brian D Gulbransen. 2020. “Pyridostigmine Bromide Exposure Creates Chronic, Underlying Neuroimmune Disruption in the Gastrointestinal Tract and Brain That Alters Responses to Palmitoylethanolamide in a Mouse Model of Gulf War Illness.” Neuropharmacology 179 (November): 108264. doi:10.1016/j.neuropharm.2020.108264.